Cancer stem cells help your mesothelioma resist chemotherapy and grow back after surgery, but a drug combination now in Phase 1 clinical trials seeks to prove those stem cells can be thwarted. The drug combination brings together the compounds VS-5584 and VS-6063, both discovered and developed by the biotech firm Verastem, Inc. VS-5584 is a